ROS-scavenging hydrogen nanotherapy simultaneously targets inflammation and pain in rheumatoid arthritis
Source abstract
Abstract
Relieving pain while treating rheumatoid arthritis (RA) is a pressing clinical need to improve satisfaction of patients, which has not received the due attention and solution. Herein, we propose a strategy to kill two birds with one stone, for which we emphasize synergetic therapeutic outcome of analgesia and inhibiting RA progression through introducing hydrogen nanogenerator to scavenge reactive oxygen species (ROS) at lesion locations. This system exhibited efficient ROS scavenging and reducing apoptosis of C17.2 cells. In a complete Freund's Adjuvant-induced RA mouse model, this controlled hydrogen release behavior significantly downregulated pro-inflammatory mediators, protecting chondrocytes from apoptosis and preventing cartilage degradation. Furthermore, hydrogen therapy could effectively restrain the release of inflammatory factors and central sensitization by alleviating mitochondrial dysfunction in peripheral neurons and inhibit NF-κB pathway. Targeting ROS, this approach represents a significant advancement in RA management, offering superior efficacy against nociplastic pain compared to conventional analgesic therapies, providing a novel treatment mode of synergistic anti-inflammatory therapy and pain management.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hydrogen's biological and therapeutic effects · Biochemical effects in animals · Vagus Nerve Stimulation Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Rheumatoid arthritis10.1016/S0140-6736(23)01525-8 ↗
2. Pain in the joints and beyond; the challenge of rheumatoid arthritis10.1016/S2665-9913(23)00094-2 ↗
3. Discrete trajectories of resolving and persistent pain in people with Rheumatoid Arthritis despite undergoing treatment for inflammation: results from three UK cohorts10.1016/j.jpain.2019.01.001 ↗
4. An interdisciplinary perspective on peripheral drivers of pain in rheumatoid arthritis10.1038/s41584-024-01155-z ↗
5. Nociplastic pain: towards an understanding of prevalent pain conditions10.1016/S0140-6736(21)00392-5 ↗
6. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine10.1016/S2665-9913(21)00032-1 ↗
7. The role of reactive oxygen species in the Rheumatoid Arthritis-associated synovial microenvironment10.3390/antiox11061153 ↗
8. Rheumatoid Arthritis - common origins, divergent mechanisms10.1056/NEJMra2103726 ↗
9. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization10.1016/j.biomaterials.2020.120390 ↗
10. The role of M1/M2 macrophage polarization in Rheumatoid Arthritis synovitis10.3389/fimmu.2022.867260 ↗
11. Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs10.3389/fimmu.2023.1107670 ↗
12. Emerging nanotherapeutics alleviating rheumatoid arthritis by readjusting the seeds and soils10.1016/j.jconrel.2022.04.001 ↗
13. Lactate-upregulated NADPH-dependent NOX4 expression via HCAR1/PI3K pathway contributes to ROS-induced osteoarthritis chondrocyte damage10.1016/j.redox.2023.102867 ↗
14. The biology of pain: through the Rheumatology Lens10.1002/art.42429 ↗
15. The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons10.1016/j.pain.2007.01.035 ↗
16. Inhibiting Hv1 channel in peripheral sensory neurons attenuates chronic inflammatory pain and opioid side effects10.1038/s41422-022-00616-y ↗
17. Precision spinal gene delivery-induced functional switch in nociceptive neurons reverses neuropathic pain10.1016/j.ymthe.2022.04.023 ↗
18. Mitochondrial ROS control neuronal excitability and cell fate in frontotemporal dementia10.1002/alz.12394 ↗
19. Reactive oxygen species affect spinal cell type-specific synaptic plasticity in a model of neuropathic pain10.1097/j.pain.0000000000001014 ↗
20. c-Src deactivation by the polyphenol 3-O-caffeoylquinic acid abrogates reactive oxygen species-mediated glutamate release from microglia and neuronal excitotoxicity10.1016/j.freeradbiomed.2014.11.019 ↗
21. Trigeminal neuralgia10.1038/s41572-024-00523-z ↗
22. The landscape of smart biomaterial-based hydrogen therapy
23. Hydrolysis of 2D Nanosheets reverses rheumatoid arthritis through anti-inflammation and osteogenesis
24. Magnesium-based micromotors as hydrogen generators for precise Rheumatoid Arthritis therapy10.1021/acs.nanolett.0c04438 ↗
25. Water-enabled H(2) generation from hydrogenated silicon nanosheets for efficient anti-inflammation10.1021/jacs.2c04412 ↗
26. Hydrogen gas improves photothermal therapy of tumor and restrains the relapse of distant dormant tumor10.1016/j.biomaterials.2019.119472 ↗
27. pH-Switched near-infrared fluorescent strategy for ratiometric detection of ONOO(-) in lysosomes and precise imaging of oxidative stress in Rheumatoid Arthritis
28. Hydrogen atom transfer from HOO(.) to ortho-Quinones explains the antioxidant activity of polydopamine10.1002/anie.202101033 ↗
29. The importance of iron in rheumatoid disease10.1016/S0140-6736(81)90590-0 ↗
30. Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidants10.1016/j.freeradbiomed.2016.06.020 ↗
31. Photoacoustic/ultrasonic dual-mode imaging for monitoring angiogenesis and synovial erosion in rheumatoid arthritis10.1016/j.pacs.2023.100458 ↗
32. Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-α-mediated ERK1/2 and JAK-STAT1 pathways10.1136/ard-2022-222605 ↗
33. Neuropathic pain: from mechanisms to treatment10.1152/physrev.00045.2019 ↗
34. A human TRPV1 genetic variant within the channel gating domain regulates pain sensitivity in rodents10.1172/JCI163735 ↗
35. TRPV1-targeted drugs in development for human pain conditions10.1007/s40265-020-01429-2 ↗
36. Highly synchronized cortical circuit dynamics mediate spontaneous pain in mice10.1172/JCI166408 ↗
37. Mike Fainzilber, Importin α3 regulates chronic pain pathways in peripheral sensory neurons10.1126/science.aaz5875 ↗
38. Stem cell exosome-loaded Gelfoam improves locomotor dysfunction and neuropathic pain in a rat model of spinal cord injury10.1186/s13287-024-03758-5 ↗
39. Sympathetic-correlated c-Fos expression in the neonatal rat spinal cord in vitro10.1186/1423-0127-16-44 ↗
40. Hydroxyl radical is a significant player in oxidative DNA damage in vivo10.1039/D1CS00044F ↗
41. Oxidative photocatalysis on membranes triggers non-canonical pyroptosis10.1038/s41467-024-47634-5 ↗
42. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model10.1186/s12974-019-1459-7 ↗
43. MicroRNA-155-5p promotes neuroinflammation and central sensitization via inhibiting SIRT1 in a nitroglycerin-induced chronic migraine mouse model10.1186/s12974-021-02342-5 ↗
44. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation